Small molecule therapeutics targeting F-box proteins in cancer

Area of Science:

• Molecular Biology
• Biochemistry
• Oncology

Background:

• The ubiquitin proteasome system (UPS) is crucial for protein homeostasis via targeted degradation.
• SCF ubiquitin E3 ligase complexes, featuring F-box proteins, mediate substrate ubiquitination and proteasomal processing.
• Dysregulation of F-box proteins is increasingly linked to various forms of neoplasia.

Purpose of the Study:

• To review the functional roles of F-box proteins in the development and progression of cancer.
• To summarize current knowledge on F-box protein-substrate interactions relevant to cancer.
• To explore the potential of small molecule inhibitors targeting F-box proteins for cancer treatment.

Main Methods:

• Literature review of studies on F-box proteins, UPS, and cancer.
• Analysis of documented F-box protein-substrate interactions in neoplastic contexts.
• Synthesis of information on existing and potential small molecule inhibitors targeting F-box proteins.

Main Results:

• F-box proteins play diverse roles in cancer, influencing cell cycle, DNA repair, and signal transduction.
• Specific F-box protein-substrate interactions are identified as critical drivers of oncogenesis.
• Several small molecule inhibitors targeting F-box proteins demonstrate preclinical efficacy in cancer models.

Conclusions:

• F-box proteins represent significant targets for anticancer drug development.
• Targeting F-box protein-substrate interactions offers a promising therapeutic strategy for various cancers.
• Further research into F-box protein biology and inhibitor development is warranted for clinical translation.